Business · 17/10/2019Updated: 10/17/2026 · 1 min read
FDA Announces Final Guidance on Prescription Drug User Fee Act Waivers, Reductions, and Refunds
Summary
The Food and Drug Administration (FDA) has released a final guidance document outlining recommendations for applicants seeking to waive or reduce user fees for prescription drugs and biological products, following a draft issued in June 2018.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →